9823 Capital’s Johnson & Johnson JNJ Stock Holding History

9823 Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,122	Closed	-$439K	–	62
2025 Q4	$439K	Buy	+2,122	New	+$420K	0.3%	22

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

9823 Capital's JNJ Position: Q1 2026 in Review

9823 Capital sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 2,122 shares — an estimated $439K sold.

9823 Capital first reported a position in JNJ in Q4 2025 and held it in 1 quarter. The position peaked at $439K in Q4 2025. 4,645 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

9823 Capital reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
9823 Capital sold 2,122 Johnson & Johnson shares in Q1 2026, an estimated $439K.
9823 Capital first reported a position in Johnson & Johnson in Q4 2025 and held it in 1 quarter.
9823 Capital's Johnson & Johnson position peaked at $439K in Q4 2025.
4,645 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on 9823 Capital's 13F filing for Q1 2026, filed 15 May 2026.